Amid overwhelming public demand for alternative COVID-19 vaccines, IHH Singapore officially began offering its first batch of 10,000 doses of the Sinopharm COVID-19 vaccine on 30 August.
With this first batch of 10,000 doses offered across Gleneagles Hospital, Mount Elizabeth Hospital and Parkway Shenton clinics in Duxton and One Raffles Quay, IHH Singapore is able to inoculate some 5,000 people.
Dr Noel Yeo, Chief Operating Officer of IHH Healthcare Singapore, said that more than 6,000 individuals had registered their interest to receive the Sinopharm vaccine even before it was made available.
"We were aware there is a demand for alternative vaccines. However, the response for Sinopharm has been overwhelming. We are making plans for second orders but we have to clear approvals from HSA (Health Sciences Authority) first,” he said.
For those looking for alternative vaccines, the Sinopharm vaccine has a reported higher efficacy rate compared to the Sinovac vaccine - 79 per cent compared to 51 per cent - and reportedly milder side effects.
Related Stories
Fortis Launches First Dedicated Lung Failure Clinic in Faridabad
Parkway MediCentre @ Woodleigh Expands Specialist Care with Asia Pacific Eye Centre
IHH Champions Health Literacy Through Quality Journalism
Harnessing AI to Advance Patient-Centred Healthcare
Artificial intelligence is rapidly transforming healthcare, creating new opportunities to enhance patient care, improve clinical efficiency and accelerate medical innovation.
Supporting Women's Health Through Open Conversations
On 10 July, the Federation of Indian Chambers of Commerce & Industry Ladies Organisation (FICCI FLO), in partnership with Fortis Healthcare, hosted Menopause 360°: Body, Mind and Hormones, an initiative dedicated to raising awareness and encouraging open conversations around menopause.
.jpg?sfvrsn=21d67f46_1)
